ARCHIVES

Ibrutinib Demonstrates 71% ORR In Phase Ib/II CLL and SLL Study

This article is from The Cancer Letter archive.

Vol. 36 No. 7 | July 26, 2013

Download PDF Visit The Full Archive

Related Articles

Study: Delaying ADT Until Symptoms Appear Can Be Safe in Men with a PSA-based Relapse

May 30, 2014

Foon Moves To UPCI

April 18, 2003

Haller Named Editor-In-Chief Of JCO; White House Appoints Duffy To NCAB.

March 17, 2000

British Award 100,000 Pounds A Year To UICC

January 11, 1980

NIH Probing: Double Dipping” Allegation

September 4, 1981

Reauthorization Bill Ready For Senate Floor; Report to Panel Makes Clear Why Renewal Needed

April 22, 1988